Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

<p>Supplementary Table S1</p>

Saved in:

書目詳細資料
主要作者:	Noor Jailkhani (16015810) (author)
其他作者:	Karl R. Clauser (16015813) (author), Howard H. Mak (14958336) (author), Steffen Rickelt (14942629) (author), Chenxi Tian (16015816) (author), Charles A. Whittaker (15038249) (author), Kenneth K. Tanabe (16015819) (author), Stephen R. Purdy (16015822) (author), Steven A. Carr (14942649) (author), Richard O. Hynes (14942641) (author)
出版:	2025
主題:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Methods and Technology Breast Cancer Imaging Positron emission tomography (PET) Small animal imaging Immunology Antibodies/immunoconjugates Proteomics Tumor Microenvironment
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
由: Noor Jailkhani (16015810)
出版: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
由: Noor Jailkhani (16015810)
出版: (2025)

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
由: Xiaojiang Duan (15439264)
出版: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
由: Xiaojiang Duan (15439264)
出版: (2025)

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
由: Xiaojiang Duan (15439264)
出版: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
由: Xiaojiang Duan (15439264)
出版: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS4 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS5 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS6 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS7 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

FigureS9 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS 1a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS1b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS1c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS1d from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS2a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS2b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary MovieS2c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
由: Jonathan Chou (14957015)
出版: (2025)

Supplementary Data S1 from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
由: Steven B. Maron (15044607)
出版: (2025)

Alternative Ion-Pairing Modifiers Should Be Investigated in Low-Input and Single-Cell Proteomics
由: Colten D. Eberhard (17729446)
出版: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
由: Abhrajit Ganguly (21540245)
出版: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
由: Marwa Zafarullah (12527002)
出版: (2025)

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 4 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Table 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
由: Friederike Hesse (14958870)
出版: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
由: Vinton W.T. Cheng (15020397)
出版: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
由: Vinton W.T. Cheng (15020397)
出版: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
由: Vinton W.T. Cheng (15020397)
出版: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
由: Vinton W.T. Cheng (15020397)
出版: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
由: Vinton W.T. Cheng (15020397)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_i68j5vjjrqp93e84vqigf9p9bm